Covance Research Products

Covance reports Signet release of new monoclonal antibodies, acquisition of company's assets

Published in Oncology Business Week, July 16th, 2006

Signet Laboratories, Inc., a medical diagnostics and research company developing monoclonal antibodies and diagnostic assays for cancer, infectious disease, and neurodegenerative disease, announced the availability of two new monoclonal antibodies L1 clone 14.10 and PTEN clone 6H2.1, according to Covance Research Products.

Covance also announced it has acquired substantially all of the assets of Signet Laboratories, Inc. Signet, which is based in Dedham, Massachusetts, is a provider of monoclonal antibodies used in the research of cancer, infectious disease, and neurodegenerative disease.

The mouse monoclonal anti-L1 clone 14.10 released by Signet...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2006-07-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry